From cancer research to DNA sequencing, the International Space Space is proving to be an ideal platform for medical research. But new techniques in fighting cancer are not confined to research on the space station. Increasingly, artificial intelligence is helping to “read” large datasets. And for the past 15 years, these big data techniques pioneered by our Jet Propulsion Laboratory have been revolutionizing biomedical research.
On Earth, scientists have devised several laboratory methods to mimic normal cellular behavior, but none of them work exactly the way the body does. Beginning more than 40 years ago aboard Skylab and continuing today aboard the space station, we and our partners have conducted research in the microgravity of space. In this environment, in vitro cells arrange themselves into three-dimensional groupings, or aggregates. These aggregates more closely resemble what actually occurs in the human body. Cells in microgravity also tend to clump together more easily, and they experience reduced fluid shear stress – a type of turbulence that can affect their behavior. The development of 3D structure and enhanced cell differentiation seen in microgravity may help scientists study cell behavior and cancer development in models that behave more like tissues in the human body.
In addition, using the distinctive microgravity environment aboard the station, researchers are making further advancements in cancer therapy. The process of microencapsulation was investigated aboard the space station in an effort to improve the Earth-based technology. Microencapsulation is a technique that creates tiny, liquid-filled, biodegradable micro-balloons that can serve as delivery systems for various compounds, including specific combinations of concentrated anti-tumor drugs. For decades, scientists and clinicians have looked for the best ways to deliver these micro-balloons, or microcapsules, directly to specific treatment sites within a cancer patient, a process that has the potential to revolutionize cancer treatment.
A team of scientists at Johnson Space Center used the station as a tool to advance an Earth-based microencapsulation system, known as the Microencapsulation Electrostatic Processing System-II (MEPS-II), as a way to make more effective microcapsules. The team leveraged fluid behavior in microgravity to develop a new technique for making these microcapsules that would be more effective on Earth. In space, microgravity brought together two liquids incapable of mixing on Earth (80 percent water and 20 percent oil) in such a way that spontaneously caused liquid-filled microcapsules to form as spherical, tiny, liquid-filled bubbles surrounded by a thin, semipermeable, outer membrane. After studying these microcapsules on Earth, the team was able to develop a system to make more of the space-like microcapsules on Earth and are now performing activities leading to FDA approval for use in cancer treatment.
In addition, the ISS National Laboratory managed by the Center for the Advancement of Science in Space (CASIS) has also sponsored cancer-related investigations. An example of that is an investigation conducted by the commercial company Eli Lilly that seeks to crystallize a human membrane protein involved in several types of cancer together with a compound that could serve as a drug to treat those cancers.
“So many things change in 3-D, it’s mind-blowing – when you look at the function of the cell, how they present their proteins, how they activate genes, how they interact with other cells,” said Jeanne Becker, Ph.D., a cell biologist at Nano3D Biosciences in Houston and principal investigator for a study called Cellular Biotechnology Operations Support Systems: Evaluation of Ovarian Tumor Cell Growth and Gene Expression, also known as the CBOSS-1-Ovarian study. “The variable that you are most looking at here is gravity, and you can’t really take away gravity on Earth. You have to go where gravity is reduced."
Our Jet Propulsion Laboratory often deals with measurements from a variety of sensors – say, cameras and mass spectrometers that are on our spacecraft. Both can be used to study a star, planet or similar target object. But it takes special software to recognize that readings from very different instruments relate to one another.
There’s a similar problem in cancer research, where readings from different biomedical tests or instruments require correlation with one another. For that to happen, data have to be standardized, and algorithms must be “taught” to know what they’re looking for.
Because space exploration and cancer research share a similar challenge in that they both must analyze large datasets to find meaning, JPL and the National Cancer Institute renewed their research partnership to continue developing methods in data science that originated in space exploration and are now supporting new cancer discoveries.
JPL’s methods are leading to the development of a single, searchable network of cancer data that researcher can work into techniques for the early diagnosis of cancer or cancer risk. In the time they’ve worked together, the two organizations’ efforts have led to the discovery of six new Food and Drug Administration-approved cancer biomarkers. These agency-approved biomarkers have been used in more than 1 million patient diagnostic tests worldwide.
Make sure to follow us on Tumblr for your regular dose of space: http://nasa.tumblr.com
New on my Skyrim to do list...
Gotta love that Bethesda programming.
I can see the good this could do, but all too easily this could be just another tool for Big Brother
At just 1.2 pounds and eight inches long, the camera-equipped rolling robot can be quite literally tossed like a football onto rooftops or through building windows. Its design ensures it lands upright in pretty much any situation where it hits a flat surface, and once deployed it can stealthily move under furniture, cars, or other cover and beam back live video to a command station 1,000 feet away. It is designed to be controlled by an operator working alongside it via a simple joystick control that also sports a small display that provides a ‘bots’-eye view.
Astronaut Kate Rubins has conducted out of this world research aboard Earth’s only orbiting laboratory. During her time aboard the International Space Station, she became the first person to sequence DNA in space. On Tuesday, she’ll be live on Facebook with National Institute of Health director Francis Collins, who led the effort to map the human genome. You can submit questions for Kate using the hashtag #SpaceChat on Twitter, or during the live event. Here’s a primer on the science this PhD astronaut has been conducting to help inspire your questions:
Kate has a background in genomics (a branch of molecular genetics that deals with the study of genomes,specifically the identification and sequencing of their constituent genes and the application of this knowledge in medicine, pharmacy,agriculture, and other fields). When she began her tenure on the station, zero base pairs of DNA had been sequenced in space. Within just a few weeks, she and the Biomolecule Sequencer team had sequenced their one billionth base of DNA aboard the orbital platform.
“I [have a] genomics background, [so] I get really excited about that kind of stuff,” Rubins said in a downlink shortly after reaching the one billion base pairs sequenced goal.
Learn more about this achievement:
+First DNA Sequencing in Space a Game Changer
+Science in Short: One Billion Base Pairs Sequenced
A space-based DNA sequencer could identify microbes, diagnose diseases and understand crew member health, and potentially help detect DNA-based life elsewhere in the solar system.
+Why Sequencing DNA in Space is a Big Deal
https://youtu.be/1N0qm8HcFRI
Miss the Reddit AMA on the subject? Here’s a transcript:
+NASA AMA: We just sequenced DNA in space for the first time. Ask us anything!
We’re not doing this alone. Just like the DNA sequencing was a collaborative project with industry, so is the Eli Lilly Hard to Wet Surfaces investigation, which is a partnership between CASIS and Eli Lilly Co. In this experiment aboard the station, astronauts will study how certain materials used in the pharmaceutical industry dissolve in water while in microgravity. Results from this investigation could help improve the design of tablets that dissolve in the body to deliver drugs, thereby improving drug design for medicines used in space and on Earth. Learn more about what we and our partners are doing:
+Eli Lilly Hard to Wet Surfaces – been happening the last week and a half or so
Researchers to Test How Solids Dissolve in Space to Design Better Tablets and Pills on Earth
With our colleagues at the Stanford University School of Medicine, we’re also investigating the effects of spaceflight on stem cell-derived heart cells, specifically how heart muscle tissue, contracts, grows and changes in microgravity and how those changes vary between subjects. Understanding how heart muscle cells change in space improves efforts for studying disease, screening drugs and conducting cell replacement therapy for future space missions. Learn more:
+Heart Cells
+Weekly Recap From the Expedition Lead Scientist for Aug. 18, 2016
Kate and her crew mates have also worked on the combustion experiments.
Kate has also worked on the Bigelow Expandable Activity Module (BEAM), an experimental expandable capsule that docks with the station. As we work on our Journey to Mars, future space habitats are a necessity. BEAM, designed for Mars or other destinations, is a lightweight and relatively simple to construct solution. Kate has recently examined BEAM, currently attached to the station, to take measurements and install sensors.
Kate recently performed a harvest of the Plant RNA Regulation experiment, by removing seed cassettes and stowing them in cold stowage.
The Plant RNA Regulation investigation studies the first steps of gene expression involved in development of roots and shoots. Scientists expect to find new molecules that play a role in how plants adapt and respond to the microgravity environment of space, which provides new insight into growing plants for food and oxygen supplies on long-duration missions. Read more about the experiment:
+Plant RNA Harvest
NASA Astronaut Kate Rubins is participating in several investigations examining changes in her body as a result of living in space. Some of these changes are similar to issues experienced by our elderly on Earth; for example, bone loss (osteoporosis), cardiovascular deconditioning, immune dysfunction, and muscle atrophy. Understanding these changes and how to prevent them in astronauts off the Earth may help improve health for all of us on the Earth. In additional, the crew aboard station is also working on more generalized studies of aging.
+ Study of the effects of aging on C. elegans, a model organism for a range of biological studies.
Purchasing power of Europe’s population by 2-digit postcodes, 2016
A recent study analyzed DNA from the teeth of Bronze Age people who lived in Europe and Asia. It found evidence of plague infection, from the Yersinia pestis bacterium, dating to 6,000 years ago! What later became the Black Plague was, 6,000 years ago, spread only through contaminated food or human-to-human contact. It was later that a genetic mutation in the bacterium allowed them to survive in the guts of fleas – researchers estimate around the turn of the 1st century BCE.
The black death’s early co-existence with humans, and its ability to pass person-to-person, also suggests an interesting new avenue for forensic diagnosing. The yersinia pestis bacterium may have been responsible for early epidemics, such as the plague of Athens. Many early plagues are known to have passed person-to-person so scientists previously discounted yersinia pestis from the running. But proving which ancient plagues were really the Black Death in an earlier form is a subject for another study.
It's only coming out in German this weekend, but wow this looks cool.
Geologists recently found evidence of ancient life in Greenland which they think dates to 3.7 billion years ago. If their findings are confirmed, that would make the fossils the oldest evidence of life yet known. The great age of the fossils makes reconstructing the evolution of life from the chemicals naturally present on the early Earth more difficult. You see, the fossils are too old. It leaves little time for evolution to have occurred, and puts the process of life emerging and evolving close to a time when Earth was being bombarded by destructive asteroids.
Mason gives a startling example of the decline of car-wash robots, to be replaced by, as he puts it “five guys with rags”. Here’s the paragraph that really made me think:
“There are now 20,000 hand car washes in Britain, only a thousand of them regulated. By contrast, in the space of 10 years, the number of rollover car-wash machines has halved –from 9,000 to 4,200.”
The reasons, of course, are political and economic and you may or may not agree with Mason’s diagnosis and prescription (as it happens I do). But de-automation – and the ethical, societal and legal implications – is something that we, as roboticists, need to think about just as much as automation.
Several questions come to mind:
are there other examples of de-automation? is the car-wash robot example atypical, or part of a trend? is de-automation necessarily a sign of something going wrong? (would Mason be so concerned about the guys with rags if the hand car wash industry were a well-regulated industry paying decent wages to its workers, and generating tax revenues back to the economy?)
Stay safe, you guys
Live wind map of hurricane Matthew – expected to make landfall in FL late tomorrow
Gaming, Science, History, Feminism, and all other manners of geekery. Also a lot of dance
243 posts